Published: 18 Mar 2026 0 views
Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center – University of Freiburg offers the position of a PhD candidate (biology, biochemistry, molecular medicine or related areas).
This PhD project is embedded within a broader research program aiming to overcome chemoresistance in acute myeloid leukemia (AML), a major cause of early relapse and treatment failure. The candidate will explore the molecular and cellular mechanisms that allow residual leukemia cells to survive therapeutic stress, focusing on metabolic adaptations and translational regulation.
Check also:
2026 Fully Funded Humboldt Research Fellowship
2026 Konrad Adenauer Foundation Scholarship
For more information, kindly visit the University of Freiburg webpage.
A friend or someone might be interested in this opportunity, kindly share.